Literature DB >> 23150760

The Roles of MDM2 and MDMX Phosphorylation in Stress Signaling to p53.

Jiandong Chen1.   

Abstract

The p53 tumor suppressor is highly responsive to different physiological stresses such as abnormal cell proliferation, nutrient deprivation, and DNA damage. Distinct signaling mechanisms have evolved to activate p53, which in turn modulate numerous pathways to enhance fitness and survival of the organism. Elucidating the molecular mechanisms of these signaling events is critical for understanding tumor suppression by p53 and development of novel therapeutics. Studies in the past decade have established that MDM2 and MDMX are important targets of signaling input from different pathways. Here, we focus our discussion on MDM2 and MDMX phosphorylation, which is important for p53 activation by DNA damage. Investigations in this area have generated new insight into the inner workings of MDM2 and MDMX and underscore the importance of allosteric communication between different domains in achieving an efficient response to phosphorylation. It is likely that MDM2 and MDMX regulation by phosphorylation will share mechanistic similarities to other signaling hub molecules. Phosphorylation-independent p53 activators such as ARF and ribosomal proteins ultimately achieve the same outcome as phosphorylation, suggesting that they may induce similar changes in the structure and function of MDM2 and MDMX through protein-protein interactions.

Entities:  

Keywords:  MDM2; MDMX; p53; phosphorylation; ubiquitination

Year:  2012        PMID: 23150760      PMCID: PMC3494364          DOI: 10.1177/1947601912454733

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  125 in total

1.  Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage.

Authors:  Yaron Pereg; Suzanne Lam; Amina Teunisse; Sharon Biton; Erik Meulmeester; Leonid Mittelman; Giacomo Buscemi; Koji Okamoto; Yoichi Taya; Yosef Shiloh; Aart G Jochemsen
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

2.  Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression.

Authors:  Connie Chao; Deron Herr; Jerold Chun; Yang Xu
Journal:  EMBO J       Date:  2006-06-01       Impact factor: 11.598

3.  Critical role for Daxx in regulating Mdm2.

Authors:  Jun Tang; Li-Ke Qu; Jianke Zhang; Wenge Wang; Jennifer S Michaelson; Yan Y Degenhardt; Wafik S El-Deiry; Xiaolu Yang
Journal:  Nat Cell Biol       Date:  2006-07-16       Impact factor: 28.824

4.  Dual-site regulation of MDM2 E3-ubiquitin ligase activity.

Authors:  Maura Wallace; Erin Worrall; Susanne Pettersson; Ted R Hupp; Kathryn L Ball
Journal:  Mol Cell       Date:  2006-07-21       Impact factor: 17.970

5.  14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.

Authors:  Yetao Jin; Mu-Shui Dai; Steven Z Lu; Yingda Xu; Zhijun Luo; Yingming Zhao; Hua Lu
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

6.  Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.

Authors:  Cynthia LeBron; Lihong Chen; Daniele M Gilkes; Jiandong Chen
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

7.  A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination.

Authors:  Peter S Brzovic; Alexei Lissounov; Devin E Christensen; David W Hoyt; Rachel E Klevit
Journal:  Mol Cell       Date:  2006-03-17       Impact factor: 17.970

8.  Enhanced phosphorylation of p53 by ATM in response to DNA damage.

Authors:  S Banin; L Moyal; S Shieh; Y Taya; C W Anderson; L Chessa; N I Smorodinsky; C Prives; Y Reiss; Y Shiloh; Y Ziv
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

9.  Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.

Authors:  N Dumaz; D W Meek
Journal:  EMBO J       Date:  1999-12-15       Impact factor: 11.598

10.  Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.

Authors:  Sarah Francoz; Pascal Froment; Sven Bogaerts; Sarah De Clercq; Marion Maetens; Gilles Doumont; Eric Bellefroid; Jean-Christophe Marine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

View more
  17 in total

1.  The cis conformation of proline leads to weaker binding of a p53 peptide to MDM2 compared to trans.

Authors:  Yingqian Ada Zhan; F Marty Ytreberg
Journal:  Arch Biochem Biophys       Date:  2015-04-01       Impact factor: 4.013

2.  AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex.

Authors:  Anna de Polo; Zhongling Luo; Casimiro Gerarduzzi; Xiang Chen; John B Little; Zhi-Min Yuan
Journal:  J Mol Cell Biol       Date:  2017-04-01       Impact factor: 6.216

3.  E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis.

Authors:  Ju Liu; C Zhang; X L Wang; P Ly; V Belyi; Z Y Xu-Monette; K H Young; W Hu; Z Feng
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

4.  MDMX under stress: the MDMX-MDM2 complex as stress signals hub.

Authors:  Anna de Polo; Varunika Vivekanandan; John B Little; Zhi-Min Yuan
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

5.  Peli1 Modulates the Subcellular Localization and Activity of Mdmx.

Authors:  Dawei Li; Omid Tavana; Shao-Cong Sun; Wei Gu
Journal:  Cancer Res       Date:  2018-03-09       Impact factor: 12.701

6.  Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.

Authors:  Haiyan Wang; Shanbao Cai; Barbara J Bailey; M Reza Saadatzadeh; Jixin Ding; Eva Tonsing-Carter; Taxiarchis M Georgiadis; T Zachary Gunter; Eric C Long; Robert E Minto; Kevin R Gordon; Stephanie E Sen; Wenjing Cai; Jacob A Eitel; David L Waning; Lauren R Bringman; Clark D Wells; Mary E Murray; Jann N Sarkaria; Lawrence M Gelbert; David R Jones; Aaron A Cohen-Gadol; Lindsey D Mayo; Harlan E Shannon; Karen E Pollok
Journal:  J Neurosurg       Date:  2016-05-13       Impact factor: 5.115

Review 7.  The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression.

Authors:  Jiandong Chen
Journal:  Cold Spring Harb Perspect Med       Date:  2016-03-01       Impact factor: 6.915

8.  MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis.

Authors:  Qingling Huang; Lihong Chen; Leixiang Yang; Xiaoling Xie; Lin Gan; John L Cleveland; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-26       Impact factor: 11.205

9.  Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry.

Authors:  Yan Zhu; Kausik Regunath; Xavier Jacq; Carol Prives
Journal:  Genes Dev       Date:  2013-08-09       Impact factor: 11.361

10.  Genetic Variations in the TP53 Pathway in Native Americans Strongly Suggest Adaptation to the High Altitudes of the Andes.

Authors:  Vanessa Cristina Jacovas; Diego Luiz Rovaris; Orlando Peréz; Soledad de Azevedo; Gabriel Souza Macedo; José Raul Sandoval; Alberto Salazar-Granara; Mercedes Villena; Jean-Michel Dugoujon; Rafael Bisso-Machado; Maria Luiza Petzl-Erler; Francisco Mauro Salzano; Patricia Ashton-Prolla; Virginia Ramallo; Maria Cátira Bortolini
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.